Hsu et al. discussed growing evidence indicating that dimeric PKM2 is released from tumor cells into the circulation of cancer patients and revealed a novel function of extracellular PKM2 in promoting cancer cell proliferation through EGFR activation. Here, PKM is linked to neoplasm.